Genital Diseases, Female  >>  veliparib (ABT-888)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

5 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
veliparib (ABT-888) / AbbVie
NCT00526617: A Phase I Study of ABT-888 in Combination With Temozolomide in Cancer Patients

Completed
1
41
NA
ABT-888, Temozolomide, Temodar, TMZ
AbbVie
Non-hematologic Malignancies, Metastatic Melanoma, Breast Cancer, Ovarian Cancer, Primary Peritoneal Cancer, Fallopian Tube Cancer, Hepatocellular Carcinoma
06/10
 
NCT02009631: A Study to Evaluate the Effects of Veliparib on Heart Rhythms in Patients With Solid Tumors

Completed
1
45
US, Europe
Veliparib (ABT-888), Placebo
AbbVie
Breast Cancer, Ovarian Cancer, Colon Cancer, Lung Cancer, Gastric Cancer, Solid Tumors
12/14
12/14
NCT02483104: Veliparib in Combination With Carboplatin And Weekly Paclitaxel in Japanese Subjects With Ovarian Cancer

Completed
1
9
Japan
veliparib, ABT-888, carboplatin, paraplatin, paclitaxel, taxol
AbbVie
Ovarian Cancer
03/16
07/16
NCT02033551: A Study Evaluating Veliparib as a Single Agent or in Combination With Chemotherapy in Subjects With Solid Tumors

Completed
1
47
US, Europe
Veliparib, ABT-888, Carboplatin, Paclitaxel, Taxol, FOLFIRI
AbbVie
Breast Cancer, Ovarian Cancer, Colon Cancer, Lung Cancer, Gastric Cancer, Solid Tumors
09/16
09/16
NCT01853306: A Study to Evaluate the Safety, Pharmacokinetics and Oral Bio Availability of Veliparib in Subjects With Solid Tumors

Completed
1
71
NA
Veliparib
AbbVie
Oncology, BRCA Mutated, High Grade Serous Ovarian Cancer, BRCA Mutated Breast Cancer
05/17
06/17

Download Options